Clinical Trial Search

Primary: Postprandial Pulse Wave Velocity (PWV) in Type 2 Diabetes Mellitus (T2DM) Participants at 30 Minutes (Mins) Pre-Breakfast — 10.99; 10.73; 11.56; 11.31 meters per second…

Primary: Change From Baseline to 12-Week Endpoint in the Functional Magnetic Resonance Imaging (fMRI) Mean Blood Oxygenation-Level-Dependent (BOLD) Response in the Amygdalae…

Primary: The Percentage of Subjects With an Average of ≥3 Spontaneous Complete Bowel Movements (SCBM) Per Week Over the 24 Week Treatment Period — 20.7; 25.1 percentage of…

Primary: Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Scale — 12.8; 9.8 units on a scale

Primary: Percent Change of Wound Size From Baseline to Last Visit — -64.98; -42.78 percentage change in wound size (cm2) — p=0.2317

Primary: Duration of Diarrhea — 2; 2 days — p=0.43

Primary: Number of Participants That Were Successfully Rehydrated — 57; 49 Participants — p=0.28

Primary: Gastromucosal Damage (GMD) Score of Paracetamol Tablet vs Ibuprofen Capsule — 0.33; 1.48 Scores on a scale — p=<0.0001

Primary: Complete Response Rate — 38; 38; 32; 32 participants

Primary: To Identify Small Intestinal Permeability Changes in Short Bowel Syndrome Patients After Administration of Recombinant Human Growth Hormone (Zorbtive®). — 7 participants

Primary: Need for Additional Uterotonic Medications — 10; 40 percentage of participants — p=<0.01

Primary: Mesopic Monocular Contrast Sensitivity Without Glare 1.5 and 3 Cycles/Degree — 1.494; 1.576; 1.410; 1.613 log contrast sensitivity units

Primary: Subjective Well-being Under Neuroleptic (SWN-20) Scale Total Score at Week 24 — 77.89 Units on a scale

Primary: Pain on Movement — 31.3; 59.2 mm

Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at 8 Weeks — -26.6; -23.7; -27.0 units on a scale — p=0.05